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Background: When potentially associated with the likelihood of outcome, missing participant data represents a
serious potential source of bias in randomized trials. Authors of systematic reviews frequently face this problem
when conducting meta-analyses. The objective of this study is to conduct a systematic survey of the relevant literature
to identify proposed approaches for how systematic review authors should handle missing participant data when
conducting a meta-analysis.
Methods: We searched MEDLINE and the Cochrane Methodology register from inception to August 2014. We
included papers that devoted at least two paragraphs to discuss a relevant approach for missing data. Five pairs
of reviewers, working independently and in duplicate, selected relevant papers. One reviewer abstracted data
from included papers and a second reviewer verified them. We summarized the results narratively.
Results: Of 9,138 identified citations, we included 11 eligible papers. Four proposed general approaches for
handling dichotomous outcomes, and all recommended a complete case analysis as the primary analysis and
additional sensitivity analyses using the following imputation methods: based on reasons for missingness (n = 3),
relative to risk among followed up (n = 3), best-case scenario (n = 2), and worst-case scenario (n = 3). Three of
these approaches suggested taking uncertainty into account. Two papers proposed general approaches for
handling continuous outcomes, and both proposed a complete case analysis as the reference analysis and
the following imputation methods as sensitivity analyses: based on reasons for missingness (n = 2), based on
the mean observed in the same trial or other trials (n = 1), and based on informative missingness differences
in means (n = 1). The remaining eligible papers did not propose general approaches but addressed specific
statistical issues.
Conclusions: All proposed approaches for handling missing participant data recommend conducting a
complete case analysis for the primary analysis and some form of sensitivity analysis to evaluate robustness of
results. Although these approaches require further testing, they may guide review authors in addressing
missing participant data.
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Missing participant data (MPD) refers to participants
excluded from the analysis of the primary study be-
cause no outcome data are available. MPD is a frequent
problem in randomized clinical trials (RCTs) [1].
Karlson et al. found that the mean attrition rate
reported in 40 trials of cognitive behavioral interven-
tions in children with a chronic medical condition was
20 % for initial follow-up and 32 % for extended follow-
up [13].
MPD may bias the effect estimates from RCTs
when its occurrence is associated with the likelihood
of outcome [1], and the risk of bias associated with
MPD at the trial level is likely to translate into a
similar risk at the meta-analysis level. Therefore, it is
important that systematic review authors address
MPD when conducting their meta-analyses and when
assessing risk of bias.
The Cochrane handbook endorses two basic ap-
proaches to handling MPD: “available case analysis” and
“analysis using imputations;” the Handbook authors clas-
sify the latter as an intention to treat analysis [17]. How-
ever, the handbook does not provide a detailed guidance
on how to approach these analyses.
Objective
The objective of this paper is to systematically survey
the methodological literature to identify proposed ap-
proaches for how systematic review authors should
handle MPD when conducting a meta-analysis.
Methods
Definition
From the perspective of a systematic review, missing
participant data refers to the outcome data of trial
participants that are not available to the reviewers
(i.e., neither from the published trial reports nor
from personal contact with trial authors) for inclu-
sion in their meta-analyses. Missing data do not re-
late to missing studies (e.g., unpublished studies) or
to unreported outcomes (e.g., outcomes planned in
trial protocols but not included in trial reports).
Eligibility criteria
We included English-language articles that devoted at
least two paragraphs to discuss methods or conceptual
approaches for how systematic reviews of RCTs could
handle MPD for dichotomous and/or continuous out-
comes. We excluded reports of systematic reviews and
reports of original studies.
Search strategy
We searched MEDLINE and the Cochrane Methodology
register from their inception dates up to August 2014using the OVID interface. An experienced researcher in
developing literature search strategies (I.S.) developed the
initial pilot search strategy. We refined the search strategy
using relevant articles identified through the pilot search.
Additional file 1 presents the detailed search strategy and
Additional file 2 presents the PRISMA checklist.
Article selection
Five pairs of reviewers trained in health research meth-
odology conducted formal calibration exercises. These
consisted of going through the same set of citations for
the purpose of ensuring good understanding of eligibility
criteria and the clarity of the instructions and forms be-
fore launching the formal screening process. Independ-
ently and in duplicate, the reviewers screened titles and
abstracts, then, and full texts for eligibility using the
web-based systematic review software (SRDistiller™). We
used standardized piloted forms and detailed written in-
structions throughout the process to optimize agree-
ment. Reviewers resolved disagreements by discussion
and with the assistance of a third reviewer when needed.
Data abstraction
One reviewer (L.K.) extracted data from included papers
and a second reviewer (E.A.) verified the abstracted data.
The remaining co-authors provided suggestions on how
to improve data synthesis and presentation. We summa-
rized our findings in both narrative and tabular formats.
Data synthesis
We calculated agreement for the full text screening stage
using the Kappa statistic. We judged the degree of agree-
ment between pairs of reviewers and interpreted it ac-
cording to Landis and Koch (k values of 0 to 0.20
represent slight agreement; 0.21 to 0.40, fair agreement;
0.41 to 0.60, moderate agreement; 0.61 to 0.80, substan-
tial agreement; and greater than 0.80 values represent al-
most perfect agreement). We synthesized the data
qualitatively and presented them in both narrative and
tabular formats.
Results
Results of the search
Additional file 3 shows the study flow. Agreement be-
tween authors for study eligibility was almost perfect
(kappa = 0.95). Out of 9138 citations, we identified 11
eligible papers reporting the following:
 Four general approaches for handling categorical
missing data (n = 4 papers) [2, 10, 12, 14]
 Two general approaches for handling continuous
missing data (n = 2) [9, 12]; (Note that Higgins
2008 addressed both categorical and continuous
data).
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for categorical missing data (n = 4 papers) [18–20, 22] and
continuous missing data (n = 2 papers) [15, 16]. Among
eight identified meeting abstracts, none addressed methods
of handling continuous and categorical missing data of trial
participants in systematic reviews.
Findings
General approaches for categorical missing data
Table 1 summarizes the four proposed general ap-
proaches for handling MPD for dichotomous outcomes.
Additional file 4 provides descriptions and illustration
of analytical methods of dealing with missing partici-
pant data. All authors recommend a complete case ana-
lysis as a primary analysis, with additional sensitivity
analyses using different imputation methods. Suggested
imputation methods include the following: based on
reasons for missingness [2, 10, 12], relative to risk
among followed up participants [2, 12, 14], best-case
scenario [10, 14], and worst-case scenario [2, 10, 14].
Three approaches suggest taking uncertainty into ac-
count [10, 12, 14]. Two papers suggested using their
approaches to assess risk of bias associated with miss-
ing data [2, 14]. One paper tested its proposed ap-
proach through simulation [10], while the remaining
three applied them to actual meta-analyses [2, 12, 14].
Of the four articles addressing specific statistical issues
for categorical missing data [18–20, 22], one discussed
correcting the bias resulting from missing data in a
meta-analysis [22] and three related articles discussed
statistical methods for allowing for uncertainty due to
missing data in meta-analysis [18–20].
General approaches for continuous missing data
Table 2 summarizes two proposed general approaches
for handling MPD for continuous outcomes [9, 12].
They both recommend a complete case analysis as a pri-
mary analysis and additional sensitivity analyses using
different imputation methods, including based on rea-
sons for missingness [9, 12], based on mean observed in
the same trial [9], based on mean observed in the other
trials [9], and based on informative missingness differ-
ences in means [12]. One approach suggests taking un-
certainty into account [12].
Of the two articles addressing specific statistical issues
for continuous missing data, one discussed pattern-mixed
model which estimates summary effects while accounting
for uncertainty in the outcome of the participants with
missing outcome data [15] and one discussed the data ac-
cording to the patterns of missing observations [16].
Description of individual approaches
Additional files 5 and 6 provide the recommendations of
each included paper addressing categorical outcomesand continuous outcomes, respectively. The text in the
additional files reproduces the paper’s own terminology
for referring to MPD. Additional file 7 presents the defi-
nitions provided by each paper for the methods used to
handle MPD in systematic reviews.
Discussion
We have summarized the recommended approaches for
how systematic review authors may handle MPD when
conducting a meta-analysis. All general approaches rec-
ommend complete case analysis as the primary analysis.
They also recommend additional sensitivity analyses
using different imputation methods, mainly to assess the
risk of bias associated with MPD. A commonly suggested
approach is basing the imputation on the risk observed
among followed up participants. Fewer approaches sug-
gest taking uncertainty into account.
This is the first systematic survey addressing recom-
mendations for the handling MPD in systematic reviews
that we are aware of. Major strengths include explicit
eligibility criteria, an exhaustive search, and systematic
approaches to study selection, data abstraction, and data
synthesis. One limitation of the review is the exclusion
of non-English studies. Although focusing on English
studies might lead to the loss of an appreciable number
of eligible studies in clinical systematic reviews [7], this
may be less of an issue for systematic surveys.
The different proposed approaches for dealing with
missing participant data have advantages and disadvan-
tages. The one proposed by Gamble and Hollis is the
only one that has been tested using a simulation study.
The approaches proposed by Higgins et al. and by Mavridis
et al. relate the imputed odds of the outcome to its ob-
served odds. The approach proposed by Akl et al. relates
the imputed incidence of the outcome to its observed inci-
dence and proposes a way to assess risk of bias associated
with missing data.
The different analytical methods included in the above
approaches have their own advantages and disadvantages.
 The complete case analysis method does not involve
any imputations, making it the preferred choice in
the main analysis. However, it typically results in
loss in power, and it assumes that the missingness
is due to reasons not related to the characteristics
of these participants nor to the outcome of
interest (missing completely at random
assumption) [21].
 The best-case scenario and worst-case scenario
methods represent implausible assumptions and
cannot be used in the main analysis. However, the
worst-case scenario might be useful in judging that
the risk of bias associated with missing participant
data as low, if its results (in a sensitivity analysis)
Table 1 Summary table of proposed general approaches for handling missing participant data for dichotomous outcomes
Complete case
analysis
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Table 2 Summary table of proposed general approaches for handling missing participant data for continuous outcomes
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analysis [2].
 Imputations using the informative missingness odds
ratio (IMOR) and the RILTFU/FU have the advantage
of basing the imputations on observed events. This
makes their use reasonable when conducting
sensitivity analyses to judge risk of bias associated
with missing participant data. The main challenge is
in determining the plausible values for these ratios.
 Any of the above imputations will increase the
count of events and consequently narrow the
confidence intervals of the effect estimate, implying
increased certainty. However, this is misleading as
the narrower confidence interval is based on
imputed data. This makes the analytical method to
handle uncertainty important to apply when using
any of the above imputation methods.
We are not aware of rigorous studies evaluating or com-
paring different approaches and analytical methods of
handling MPD in systematic review. While a large number
of such studies have been published for trials [3, 11], their
results do not directly inform the approach for systematic
reviews. While trialists can use individual participant data
to apply advanced statistical techniques such as multiple
imputations [11], systematic reviewers can only use group
level data with their inherent limitation, except in the case
of individual participant data meta-analyses.
It is important to note the difference between a complete
case analysis and per protocol analysis. Complete case ana-
lysis is intended to deal with the problem of participants
with missing outcome data while per protocol analysis is
intended to deal with the problem of non-compliant partic-
ipants. The complete case analysis includes only partici-
pants with available outcome data. Per protocol analysis
includes only participants who were compliant with the
study protocol. The use of one analysis is independent of
the use of the other. Indeed, Alshurafa et al. call for dealing
with these two issues separately [4].
While the Cochrane Collaboration’s software (RevMan)
does not include a module to account for missing data in
meta-analysis, STATA has one for dichotomous data [8].
The “metamiss” command allows a complete case analysis
as well as analyses applying a range of assumptions about
the outcomes of participants with missing data [8]. It also
applies the Gamble-Hollis analysis, which inflates the
pooled effect estimate to reflect the uncertainty asso-
ciated with missing data. Other software may have
similar modules.
While the approaches we have identified require
further testing, they may guide review authors facing
missing participant data in their analysis. Systematic re-
viewers should also aim to minimize MPD by contacting
the trialists to obtain unpublished but available data. Inthe unlikely case where trialists publish the outcomes of
participants excluded from the trial analysis, the system-
atic reviewers may analyze them in the groups to which
they were randomized.
The approaches presented in this systematic survey do
require further empirical assessment. Indeed none of the
imputation methods (including IMOR and RI) have been
validated. Assessment could include simulation studies
assessing the performance of the different approaches
for handling MPD when conducting a meta-analysis, in
relation to the truth [6]. Assessment could also compare
the effect of the different approaches on pooled effect esti-
mates, when applied to a sample of published systematic
reviews. The findings of those investigations could then
form the basis for consensus guidance on reporting, deal-
ing with, and judging risk of bias associated with missing
participant data in meta-analyses of randomized trials.Conclusions
Based on our findings, and pending further empirical
evaluation, we suggest the following approach for hand-
ling MPD in a meta-analysis.
 First, calculate the best estimate of effect
(primary analysis) using a complete case analysis.
 Then, assess the risk of bias associated with missing
data by evaluating the robustness of the best
estimate of effect (sensitivity analyses). These
sensitivity analyses would consist of imputing the
outcomes of participants with missing data using
plausible assumptions.
The authors of systematic reviews can base the as-
sumptions on reasons for missingness or estimate risks
among participants with missing data relative to risk
among those with available data. Further, approaches
may (or may not) take uncertainty of the values attrib-
uted to the missing data into account.Additional files
Additional file 1: Search strategy. Search strategy using Cochrane
Methodology register and Ovid MEDLINE(R) In-Process and Other
Non-Indexed Citations <1946 to Present >.
Additional file 2: PRISMA 2009 Checklist.
Additional file 3: PRISMA 2009 Flow Diagram.
Additional file 4: Descriptions and illustration of analytical
methods of dealing with missing participant data different
sensitivity analyses of one trial. Numerical data and results of
different sensitivity analyses of one trial addressing perioperative
anticoagulation in patients with cancer [5].
Additional file 5: Recommendations of each included paper
addressing categorical outcomes. The text here reproduces the paper’s
own terminology for referring missing participant data terminology.
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addressing continuous outcomes. The text here reproduces the
paper’s own terminology for referring missing participant data
terminology.
Additional file 7: Definitions provided for the methods used to
handle MPD in systematic reviews.
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